(Q36371223)

13 August 2017

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy (English)

1 reference

13 August 2017

hepatocellular carcinoma

1 reference

1 reference

Yasunari Nakamoto

1

1 reference

13 August 2017

Shuichi Kaneko

2

1 reference

13 August 2017

Hong Fan

3

1 reference

13 August 2017

Takashi Momoi

4

1 reference

13 August 2017

Hiroko Tsutsui

5

1 reference

13 August 2017

Kenji Nakanishi

6

1 reference

13 August 2017

Kenichi Kobayashi

7

1 reference

13 August 2017

Takashi Suda

8

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Journal of Experimental Medicine

13 August 2017

1 reference

13 August 2017

196

1 reference

13 August 2017

8

1 reference

13 August 2017

1105-1111

1 reference

Immune pathogenesis of hepatocellular carcinoma.

13 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Hepatitis B virus immunopathology

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

High-level hepatitis B virus replication in transgenic mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Expression of the Fas ligand in cells of T cell lineage.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Fas ligand expression in islets of Langerhans does not confer immune privilege and instead targets them for rapid destruction

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Immunobiology and pathogenesis of hepatocellular injury in hepatitis B virus transgenic mice

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Detection of activated caspase-3 (CPP32) in the vertebrate nervous system during development by a cleavage site-directed antiserum

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2194047

Protection or damage: a dual role for the virus-specific cytotoxic T lymphocyte response in hepatitis B and C infection?

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.20020633

Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1084%2FJEM.20020633

Fas engagement accelerates liver regeneration after partial hepatectomy

21 January 2018

1 reference

12 December 2020

Caspase-1-independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice

1 reference

12 December 2020

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

12 December 2020

Risk factors for hepatocellular carcinoma among patients with chronic liver disease

1 reference

12 December 2020

Antitumor effect of locally produced CD95 ligand

1 reference

12 December 2020

Essential roles of the Fas ligand in the development of hepatitis

1 reference

12 December 2020

Propionibacterium acnes treatment diminishes CD4+ NK1.1+ T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells

1 reference

12 December 2020

Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand

1 reference

12 December 2020

Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease

1 reference

12 December 2020

Identifiers

DOI

10.1084/JEM.20020633

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

12391022

1 reference